All Stories

  1. 1295 Spatial characterization of T-cell and B-cell receptors at subcellular resolution using in situ sequencing-by-synthesis of constant and variable segments
  2. CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma
  3. Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas construction and usage
  4. Author Correction: IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
  5. IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease
  6. Abstract 4308: Same-section spatial multiomic analyses using MICS technology for investigating the dynamics of the tumor microenvironment
  7. Abstract 4953: A proposal to extend standardized organ mapping antibody panels (OMAPs) to integrate protein and RNA analysis in spatial biology
  8. Abstract 5565: Multiomic characterization of colorectal cancer using MICS technology reveals interaction of antigen presenting cancer associated fibroblasts and T cells
  9. Spatial protein and RNA analysis on the same tissue section using MICS technology
  10. Organ Mapping Antibody Panels: a community resource for standardized multiplexed tissue imaging
  11. Abstract 5633: Analysis of the immune microenvironment and tumor-infiltrating immune cells across different solid tumors by combined spatial transcriptomics and proteomics
  12. Data from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  13. Figure S1 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  14. Figure S1 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  15. Figure S2 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  16. Figure S2 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  17. Figure S3 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  18. Figure S3 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  19. Figure S4 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  20. Figure S4 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  21. Supplementary Information from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  22. Supplementary Information from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  23. Table S1 and S2 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  24. Table S1 and S2 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  25. Table S3-S6 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  26. Table S3-S6 from Ribonucleotide Excision Repair Is Essential to Prevent Squamous Cell Carcinoma of the Skin
  27. Nfkb2 deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
  28. Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation
  29. Genetic diversity of honeybee colonies predicts gut bacterial diversity of individual colony members
  30. Abstract 2813: Identification of a novel tumor marker combination THY1-EPCAM for adaptor CAR T cell therapy in ovarian cancer
  31. Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation
  32. A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant inhibitory impact on CSF1R signalling
  33. Effects of Human RelA Transgene on Murine Macrophage Inflammatory Responses
  34. Author Correction: EMPReSS: standardized phenotype screens for functional annotation of the mouse genome
  35. MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors
  36. A kinase-dead Csf1r mutation associated with adult-onset leukoencephalopathy has a dominant-negative impact on CSF1R signaling
  37. MACSima Imaging Cyclic Staining (MICS) Technology Reveals Combinatorial Target Pairs for CAR T Treatment of Solid Tumors
  38. Trichuris muris infection drives cell-intrinsic IL4R alpha independent colonic RELMα+ macrophages
  39. Advanced high dynamic range fluorescence microscopy with Poisson noise modeling and integrated edge-preserving denoising
  40. Impact of Interleukin 10 Deficiency on Intestinal Epithelium Responses to Inflammatory Signals
  41. The genetic diversity of honeybee colonies predicts the gut bacterial diversity of individual colony members
  42. Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells
  43. The role of β2 integrin in dendritic cell migration during infection
  44. Cell-intrinsic IL4R alpha independence of large intestinal RELMα+ Ym1+ macrophages
  45. A Transgenic Line That Reports CSF1R Protein Expression Provides a Definitive Marker for the Mouse Mononuclear Phagocyte System
  46. Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge
  47. The Generation of an Engineered Interleukin-10 Protein With Improved Stability and Biological Function
  48. Investigating the importance of B cells and antibodies during Trichuris muris infection using the IgMi mouse
  49. A transgenic line that reports CSF1R protein expression provides a definitive marker for the mouse mononuclear phagocyte system
  50. Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease
  51. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection
  52. Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
  53. The Essential Role Played by B Cells in Supporting Protective Immunity Against Trichuris muris Infection Is by Controlling the Th1/Th2 Balance in the Mesenteric Lymph Nodes and Depends on Host Genetic Background
  54. Review for "Identifying the variables that drive tamoxifen‐independent CreERT2 recombination: implications for microglial fate mapping and gene deletions"
  55. Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
  56. Permeability analyses and three dimensional imaging of interferon gamma-induced barrier disintegration in intestinal organoids
  57. The essential role played by B cells in supporting protective immunity against Trichuris muris infection is dependent on host genetic background and is independent of antibody
  58. Macrophage-specific NF-kappa B activation dynamics can segregate inflammatory bowel disease patients: Supplementary information
  59. Human TNF-Luc reporter mouse: A new model to quantify inflammatory responses
  60. Exclusive dependence of IL-10Rα signalling on intestinal microbiota homeostasis and control of whipworm infection
  61. IL‐10 signaling in dendritic cells is required for tolerance induction in a murine model of allergic airway inflammation
  62. Innate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis
  63. Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons
  64. Distinct Roles for CD4+ Foxp3+ Regulatory T Cells and IL-10–Mediated Immunoregulatory Mechanisms during Experimental Visceral Leishmaniasis Caused by Leishmania donovani
  65. Evaluating the IgMi mouse as a novel tool to study B cell biology
  66. Ribonucleotide excision repair is essential to prevent squamous cell carcinoma of the skin.
  67. Unimpaired Responses to Vaccination With Protein Antigen Plus Adjuvant in Mice With Kit-Independent Mast Cell Deficiency
  68. Quantitative analysis of competitive cytokine signaling predicts tissue thresholds for the propagation of macrophage activation
  69. Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice
  70. OTU-001 Identification of a novel therapeutic agent for treating IBD guided by systems medicine
  71. P003 Identification of a novel therapeutic agent for treating Crohn’s disease guided by systems medicine
  72. Although Abundant in Tumor Tissue, Mast Cells Have No Effect on Immunological Micro-milieu or Growth of HPV-Induced or Transplanted Tumors
  73. Innate Sensing by Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis
  74. IL-6–Type Cytokine Signaling in Adipocytes Induces Intestinal GLP-1 Secretion
  75. Gamma Interferon Mediates Experimental Cerebral Malaria by Signaling within Both the Hematopoietic and Nonhematopoietic Compartments
  76. Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor
  77. Author response: Macrophage dysfunction initiates colitis during weaning of infant mice lacking the interleukin-10 receptor
  78. Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses
  79. DOP049 Inflammatory dyskinesis: defects of NF-κB dynamic behaviour as a new potential biomarker for personalized medicine in inflammatory bowel disease
  80. IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF + Th17 cells
  81. Uncoupling of mucosal gene regulation, mRNA splicing and adherent microbiota signatures in inflammatory bowel disease
  82. Making sense of big data in health research: Towards an EU action plan
  83. CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation
  84. IL-23 compensates for the absence of IL-1 signaling on CD4 T cells in EAE model
  85. Myeloid interferon-γ receptor deficiency does not affect atherosclerosis in LDLR-/- mice
  86. Correction: Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology
  87. Characterization of a conditional interleukin-1 receptor 1 mouse mutant using the Cre/LoxP system
  88. Blimp-1-Dependent IL-10 Production by Tr1 Cells Regulates TNF-Mediated Tissue Pathology
  89. Colonic gene silencing using siRNA-loaded calcium phosphate/PLGA nanoparticles ameliorates intestinal inflammation in vivo
  90. Mesenteric Fat Lipolysis Mediates Obesity-associated Hepatic Steatosis and Insulin Resistance
  91. Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics
  92. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System
  93. IFNγ signaling endows DCs with the capacity to control type I inflammation during parasitic infection through promoting T-bet+ regulatory T cells (IRC7P.421)
  94. IFNγ Signaling Endows DCs with the Capacity to Control Type I Inflammation during Parasitic Infection through Promoting T-bet+ Regulatory T Cells
  95. Extracellular Vesicles from Neural Stem Cells Transfer IFN-γ via Ifngr1 to Activate Stat1 Signaling in Target Cells
  96. 105
  97. Extracellular Vesicles from Neural Stem Cells Transfer IFN-γ via Ifngr1 to Activate Stat1 Signaling in Target Cells
  98. Extracellular vesicles from neural stem cells transfer the IFN-γ/IFNGR1 complex to activate Stat1-dependent signalling in target cells
  99. Regulatory T cells and T‐cell‐derived IL‐10 interfere with effective anti‐cytomegalovirus immune response
  100. Transient Ablation of Regulatory T cells Improves Antitumor Immunity in Colitis-Associated Colon Cancer
  101. Glycoprotein 130 Receptor Signaling Mediates  -Cell Dysfunction in a Rodent Model of Type 2 Diabetes
  102. Malaria Parasite Infection Compromises Control of Concurrent Systemic Non-typhoidal Salmonella Infection via IL-10-Mediated Alteration of Myeloid Cell Function
  103. Macrophage-Restricted Interleukin-10 Receptor Deficiency, but Not IL-10 Deficiency, Causes Severe Spontaneous Colitis
  104. Interleukin-10 Receptor Signaling in Innate Immune Cells Regulates Mucosal Immune Tolerance and Anti-Inflammatory Macrophage Function
  105. 406 A Self-Reinforcing Pathway of Protective Mucosal Immunity Mediated by Epithelial CD1d
  106. Protective mucosal immunity mediated by epithelial CD1d and IL-10
  107. Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
  108. IFN- -Mediated Induction of an Apical IL-10 Receptor on Polarized Intestinal Epithelia
  109. TGF-β Signalling Is Required for CD4+ T Cell Homeostasis But Dispensable for Regulatory T Cell Function
  110. Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
  111. Neuroprotective intervention by interferon-γ blockade prevents CD8 + T cell–mediated dendrite and synapse loss
  112. Monocyte-Derived Dendritic Cells Perform Hemophagocytosis to Fine-Tune Excessive Immune Responses
  113. Mouse SAMHD1 Has Antiretroviral Activity and Suppresses a Spontaneous Cell-Intrinsic Antiviral Response
  114. T Cell-Derived IL-10 Determines Leishmaniasis Disease Outcome and Is Suppressed by a Dendritic Cell Based Vaccine
  115. CD4+ T Cell-derived IL-10 Promotes Brucella abortus Persistence via Modulation of Macrophage Function
  116. T-cell-derived, but not B-cell-derived, IL-10 suppresses antigen-specific T-cell responses inLitomosoides sigmodontis-infected mice
  117. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains
  118. Site-specific immunophenotyping of keloid disease demonstrates immune upregulation and the presence of lymphoid aggregates
  119. IL-10 Acts As a Developmental Switch Guiding Monocyte Differentiation to Macrophages during a Murine Peritoneal Infection
  120. β7 integrin controls immunogenic and tolerogenic mucosal B cell responses
  121. Neuronal gp130 Expression Is Crucial to Prevent Neuronal Loss, Hyperinflammation, and Lethal Course of Murine Toxoplasma Encephalitis
  122. Strong Impact of CD4+Foxp3+ Regulatory T Cells and Limited Effect of T Cell-Derived IL-10 on Pathogen Clearance during Plasmodium yoelii Infection
  123. Studying Immunology in Mice
  124. Adaptive Immune Response to Model Antigens Is Impaired in Murine Leukocyte-Adhesion Deficiency-1 Revealing Elevated Activation ThresholdsIn Vivo
  125. IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection
  126. Induction of Regulatory T Cells by a Murine  -Defensin
  127. B Cell-Derived IL-10 Does Not Regulate Spontaneous Systemic Autoimmunity in MRL.Faslpr Mice
  128. Commensal gut flora reduces susceptibility to experimentally induced colitis via T-cell-derived interleukin-101
  129. Autocrine Regulation of Pulmonary Inflammation by Effector T-Cell Derived IL-10 during Infection with Respiratory Syncytial Virus
  130. Pro-B cells sense productive immunoglobulin heavy chain rearrangement irrespective of polypeptide production
  131. Mast Cells Are Key Promoters of Contact Allergy that Mediate the Adjuvant Effects of Haptens
  132. gp130 on macrophages/granulocytes modulates inflammation during experimental tuberculosis
  133. Gp130-Dependent Release of Acute Phase Proteins Is Linked to the Activation of Innate Immune Signaling Pathways
  134. Gp130-Dependent Astrocytic Survival Is Critical for the Control of Autoimmune Central Nervous System Inflammation
  135. Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated Inflammation
  136. High-throughput mouse phenotyping
  137. IL-10 production by B cells is not required for B cell-mediated suppression of contact allergy (163.24)
  138. Intestinal Tolerance Requires Gut Homing and Expansion of FoxP3+ Regulatory T Cells in the Lamina Propria
  139. TLR-2-Activated B Cells Suppress Helicobacter-Induced Preneoplastic Gastric Immunopathology by Inducing T Regulatory-1 Cells
  140. Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit
  141. Transgenic mice with a diverse human T cell antigen receptor repertoire
  142. Continuous Glycoprotein-130–Mediated Signal Transducer and Activator of Transcription-3 Activation Promotes Inflammation, Left Ventricular Rupture, and Adverse Outcome in Subacute Myocardial Infarction
  143. Differential Roles of Macrophages in Diverse Phases of Skin Repair
  144. Monocytes/macrophages and/or neutrophils are the target of IL‐10 in the LPS endotoxemia model
  145. Screening of Natural Compounds Affecting Type I Interferon Signalling
  146. Analysis of Single Chain Antibody Sequences Using the VBASE2 Fab Analysis Tool
  147. Preconditioning-induced protection of photoreceptors requires activation of the signal-transducing receptor gp130 in photoreceptors
  148. EuroPhenome: a repository for high-throughput mouse phenotyping data
  149. Hepatocyte gp130 Deficiency Reduces Vascular Remodeling After Carotid Artery Ligation
  150. A Key Role for gp130 Expressed on Peripheral Sensory Nerves in Pathological Pain
  151. Langerhans Cells Suppress Contact Hypersensitivity Responses Via Cognate CD4 Interaction and Langerhans Cell-Derived IL-10
  152. Charles River altered Schaedler flora (CRASF®) remained stable for four years in a mouse colony housed in individually ventilated cages
  153. Mucosal Addressin Cell-Adhesion Molecule-1 Controls Plasma-Cell Migration and Function in the Small Intestine of Mice
  154. T‐cell‐specific deletion of gp130 renders the highly susceptible IL‐10‐deficient mouse resistant to intestinal nematode infection
  155. Nonredundant Roles for B Cell-Derived IL-10 in Immune Counter-Regulation
  156. Conditional deletion of the MHC class I-related receptor FcRn reveals the sites of IgG homeostasis in mice
  157. The German Mouse Clinic: A Platform for Systemic Phenotype Analysis of Mouse Models
  158. Functional knockdown of VCAM-1 at the posttranslational level with ER retained antibodies
  159. IL-20 Receptor 2 Signaling Down-Regulates Antigen-Specific T Cell Responses
  160. Excessive CpG 1668 stimulation triggers IL‐10 production by cDC that inhibits IFN‐α responses by pDC
  161. Astrocyte gp130 Expression Is Critical for the Control of Toxoplasma Encephalitis
  162. Conditional gp130 deficient mouse mutants
  163. Role of β7 Integrin and the Chemokine/Chemokine Receptor Pair CCL25/CCR9 in Modeled TNF-Dependent Crohn's Disease
  164. GP130-STAT3 Regulates Epithelial Cell Migration and Is Required for Repair of the Bronchiolar Epithelium
  165. Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis
  166. Susceptibility of four inbred mouse strains to a low-pathogenic isolate of Yersinia enterocolitica
  167. Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
  168. Synthetic Mimetics of the gp130 Binding Site for Viral Interleukin-6 as Inhibitors of the vIL-6-gp130 Interaction
  169. Integration of Mouse Phenome Data Resources
  170. Distinct Functions of Interleukin-10 Derived from Different Cellular Sources
  171. Astrocyte gp130-expression is critical for the control of Toxoplasma encephalitis
  172. Mast cell-specific Cre/loxP-mediated recombination in vivo
  173. LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1
  174. Contribution of Interleukin‐6/gp130 Signaling in Hepatocytes to the Inflammatory Response in Mice Infected with Streptococcus pyogenes
  175. Reply to “TSLP-mediated fetal B lymphopoiesis?”
  176. The adhesion receptor CD155 determines the magnitude of humoral immune responses against orally ingested antigens
  177. Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man
  178. Serum Response Factor Contributes Selectively to Lymphocyte Development
  179. Integration of mouse phenome data resources
  180. Interleukin-10 derived from macrophages and/or neutrophils regulates the inflammatory response to LPS but not the response to CpG DNA
  181. Dissecting the cytokine network
  182. Adult murine hematopoiesis can proceed without beta1 and beta7 integrins
  183. Expression Analysis In Vivo
  184. A change of expression in the conserved signaling gene MKK7 is associated with a selective sweep in the western house mouse Mus musculus domesticus
  185. Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in  2 integrin-deficient mice
  186. gp130 signaling in proopiomelanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor
  187. Phenotyping of Host‐Pathogen Interactions in Mice
  188. Enhanced FTY720-Mediated Lymphocyte Homing Requires G i Signaling and Depends on  2 and  7 Integrin
  189. Nine fluorescence parameter analysis on a four-color fluorescence activated flow cytometer
  190. Corrigendum to “Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo” [Free Radic. Biol. Med. 38:1458–1470; 2005]
  191. EMPReSS: standardized phenotype screens for functional annotation of the mouse genome
  192. Virus free, cell-based assay for the quantification of murine type I interferons
  193. Introducing the German Mouse Clinic: open access platform for standardized phenotyping
  194. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo
  195. VBASE2, an integrative V gene database
  196. T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation
  197. The European dimension for the mouse genome mutagenesis program
  198. Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment
  199. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte-expressed protein
  200. Generation of Mouse Mutants by Sequence Information Driven and Random Mutagenesis
  201. CD4+ T Cell-Associated Pathophysiology Critically Depends on CD18 Gene Dose Effects in a Murine Model of Psoriasis
  202. Lack of gp130 expression in hepatocytes promotes liver injury1 1K.L.S. and T.W. contributed equally to this work.
  203. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting
  204. Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development
  205. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases
  206. Mice with neonatally induced inactivation of the vascular cell adhesion molecule-1 fail to control the parasite in Toxoplasma encephalitis
  207. IL-15 is an essential mediator of peripheral NK-cell homeostasis
  208. Interleukin-6/Glycoprotein 130-dependent Pathways Are Protective during Liver Regeneration
  209. ??7 integrins contribute to skin graft rejection
  210. β 7 Integrin expression is not required for the localization of T cells to the intestine and colitis pathogenesis
  211. Integrin  2-Deficient Mice Develop Normally, Are Fertile, but Display Partially Defective Platelet Interaction with Collagen
  212. Role of STAT3 and PI 3-Kinase/Akt in Mediating the Survival Actions of Cytokines on Sensory Neurons
  213. Neonatally Induced Inactivation of the Vascular Cell Adhesion Molecule 1 Gene Impairs B Cell Localization and T Cell–Dependent Humoral Immune Response
  214. Antikörper-vermittelte Blockade von β7 Integrinen, jedoch nicht deren „Knockout“ verlängert das Überleben allogener Dünndarmtransplantate in der Maus.
  215. α4β7 independent pathway for CD8+ T cell–mediated intestinal immunity to rotavirus
  216. Despite high levels of lymphocyte homing receptor α4β7 integrin after small bowel allotransplantation, it is not critical for rejection
  217. Cloning of the Murine Thymic Stromal Lymphopoietin (Tslp) Receptor
  218. Blockade of the integrin alpha Lbeta 2 but not of integrins alpha 4 and/or beta 7 significantly prolongs intestinal allograft survival in mice
  219. β7 integrin-deficient mice: delayed leukocyte recruitment and attenuated protective immunity in the small intestine during enteric helminth infection
  220. Common cytokine receptor γ chain (γc)-deficient B cells persist in T cell-deficient γc mice and respond to a T-independent antigen
  221. Mice reconstituted with DNA polymerase β-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their Ig genes normally
  222. β7 integrins contribute to demyelinating disease of the central nervous system
  223. Chronic Colitis in IL-10-/-Mice: Insufficient Counter Regulation of a Th1 Response
  224. The Role of β7 Integrins in CD8 T Cell Trafficking During an Antiviral Immune Response
  225. Loss of a gp130 Cardiac Muscle Cell Survival Pathway Is a Critical Event in the Onset of Heart Failure during Biomechanical Stress
  226. Rearrangement and Expression of Immunoglobulin Light Chain Genes Can Precede Heavy Chain Expression during Normal B Cell Development in Mice
  227. IMGT, the international ImMunoGeneTics database
  228. Postnatally Induced Inactivation of gp130 in Mice Results in Neurological, Cardiac, Hematopoietic, Immunological, Hepatic, and Pulmonary Defects
  229. L-selectin and β7 integrin synergistically mediate lymphocyte migration to mesenteric lymph nodes
  230. Regulated expression of gp130 and IL-6 receptor alpha chain in T cell maturation and activation
  231. Efficient homing of CD4+ cells to the gut mucosa is necessary for colitis pathogenesis, but may not be required for the down regulation of pathogenic T cells
  232. IMGT, the International ImMunoGeneTics database
  233. Functions of α4- and β7-Integrins in Hematopoiesis, Lymphocyte Trafficking and Organ Development
  234. IMGT, the International ImMunoGeneTics Database: a New Design for Immunogenetics Data Access
  235. Histological studies of gene-ablated mice support important functional roles for natural killer cells in the uterus during pregnancy
  236. Generation of Cre recombinase-specific monoclonal antibodies, able to characterize the pattern of Cre expression in cre-transgenic mouse strains
  237. On the role of the common cytokine receptor γ chain in B-cell vs. T-cell development
  238. Introduction
  239. Conditional inactivation of gp130 in mice
  240. Interleukin-4 Protects against a Genetically Linked Lupus-like Autoimmune Syndrome
  241. IMGT, the international ImMunoGeneTics database
  242. Introduction of Defined Mutations into the Mouse Germline
  243. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
  244. Plasmodium chabaudi chabaudi:Differential Susceptibility of Gene-Targeted Mice Deficient in IL-10 to an Erythrocytic-Stage Infection
  245. Impaired Immunosuppressive Response to Ultraviolet Radiation in Interleukin-10–Deficient Mice
  246. Bypass of lethality with mosaic mice generated by Cre–loxP-mediated recombination
  247. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
  248. Somatic hypermutation occurs in B cells of terminal deoxynucleotidyl transferase-, CD23-, interleukin-4-, IgD- and CD30-deficient mouse mutants
  249. Conditional gene targeting.
  250. Critical role for β7 integrins in formation of the gut-associated lymphoid tissue
  251. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice
  252. Prolonged islet allograft acceptance in the absence of interleukin 4 expression
  253. Surrogate Light Chain Expression Is Required to Establish Immunoglobulin Heavy Chain Allelic Exclusion during Early B Cell Development
  254. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice
  255. Cytokine-Deficient Mouse Mutants
  256. Common Cytokine Receptor gamma chain (gammac)-Dependent Cytokines: Understanding in vivo Functions by Gene Targeting
  257. Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.
  258. A role for CD5 in TCR-mediated signal transduction and thymocyte selection
  259. Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses
  260. Altered immune responses in mice lacking inducible nitric oxide synthase
  261. Immunological techniques
  262. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain.
  263. Interleukin-10 Deficient Mice
  264. Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies
  265. Leishmania major and Toxoplasma gondii have opposite effects on cytokine synthesis by macrophages
  266. IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF- beta and IL-4, and is inhibited by IFN-gamma.
  267. Interleukin-10-deficient mice: A model of chronic inflammatory disease
  268. Lymphocyte populations and immune responses in CD5-deficient mice
  269. Analysis of the B-cell progenitor compartment at the level of single cells
  270. Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells
  271. Early B-Cell Development in the Mouse: Insights from Mutations Introduced by Gene Targeting
  272. Development and proliferation of lymphocytes in mice deficient for both interleukins-2 and -4
  273. Interleukin-10-deficient mice develop chronic enterocolitis
  274. Immunoglobulin heavy and light chain genes rearrange independently at early stages of B cell development
  275. Interleukin-4-deficient mice
  276. Interleukin 10 and the Inflammatory Response
  277. Allelic exclusion model questioned
  278. T helper cell membranes promote IL-4-independent expression of germ-line C gamma 1 transcripts in B cells
  279. Analysis of cytokine mRNA levels in interleukin-4-transgenic mice by quantitative polymerase chain reaction
  280. A critical role of λ5 protein in B cell development
  281. Generation and analysis of interleukin-4 deficient mice
  282. Generation of long-lived B cells in germ-free mice
  283. Most peripheral B cells in mice are ligand selected
  284. Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer
  285. Major histocompatibility complex class II hyperexpression on B cells in interleukin 4-transgenic mice does not lead to B cell proliferation and hypergammaglobulinemia
  286. CD5 B Cells in the Mouse
  287. Retroviral interleukin 4 gene transfer into an interleukin 4-dependent cell line results in autocrine growth but not in tumorigenicity
  288. High gradient magnetic cell separation with MACS
  289. Innere Medizin
  290. A retroviral expression vector containing murine immunoglobullin heavy chain promoter/enhancer
  291. c-fos expression interferes with thymus development in transgenic mice
  292. A new V gene expressed in lambda-2 light chains of the mouse
  293. A T cell clone which responds to interkeukin 2 but not to interleukin 4
  294. Class switch recombination is IgG1 specific on active and inactive IgH loci of IgG1-secreting B-cell blasts.
  295. Control of Immunoglobulin Class Switch Recombination
  296. Modulation of interleukin 2 activity by lymphocyte-derived tetrahydrobiopterin
  297. Heterogeneous and monoclonal helper T cells induce similar anti‐(4‐hydroxy‐3‐nitrophenyl)acetyl (NP) antibody populations in the primary adoptive response I. Isotype distribution
  298. Intercellular communication and cell cooperation in growth control of T-lymphocytes
  299. Mycoplasma contamination in human tumor cell lines: effect on interferon induction and susceptibility to natural killing.
  300. Novel Cell-based Assay for the Detection of Murine type I IfN